MedTrace Logo

The PSIQS Study - User Experience With Pro-Set

NCT03242005 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-09-14

No results posted yet for this study

Summary

Open label, randomized 2-period cross-over study comparing two continuous subcutaneous insulin infusion sets ; MiniMed® Pro-set® with BD FlowSmart™ technology and MiniMed® Quick-set®

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

MiniMed® Pro-set®

Utilization of the MiniMed® Pro-set® to administer the subject's current insulin therapy.

DEVICE

MiniMed® Quick-set®

Utilization of the MiniMed® Quick-set® to administer the subject's current insulin therapy.

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
13 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-30
Primary Completion
2017-12-31
Completion
2018-02-28
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242005 on ClinicalTrials.gov